BIRC5 and cancer: The data showing that a reduction in endogenous NO derived from endothelium promotes survivin upregulation, and the exogenous NO to reduces PDGF stimulated survivin levels extends the observation that high concentrations of NO donor drugs decrease survivin expression in a variety of cancer cells [29].